VISEN Pharmaceuticals - B Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by LU AN-BANG, was filed 02 Jul 2025.
VISEN Pharmaceuticals - B: what insiders have been doing
VISEN Pharmaceuticals - B belongs to the Health Care sector. Filings by its managers are published through HKEX. In the past year (22 October 2025 to 22 October 2026), 2 filings came from 1 insider.
There is no open-market purchase to report; the filings show 1 sale by 1 insider. The totals do not cover 1 filing with an undisclosed amount.
Compared with its exchange (1,314 companies, median 4 filings), a count of 2 filings is below the norm. Over the whole record (from 2025), the tally stands at 1 purchase and 1 sale.
A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
In the same sector, recent insider purchases at UCB also feature in our signals. This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 108,750 sharesShareXHKGHKEX:DA20260427E00462
- 3,500,000 sharesShareXHKGHKEX:DA20260427E00463
- 435,000 sharesShareXHKGHKEX:DA20250702E00189Canonical exit: 25 Sept 2025 (T+90)
- 1,707,700 sharesShareXHKGHKEX:DA20250428E00429
- 5,000,000 sharesShareXHKGHKEX:DA20250401E00114
5 of 5 declarations
About VISEN Pharmaceuticals - B
VISEN Pharmaceuticals - B is a company focused on developing innovative treatments in the healthcare and pharmaceutical sector. It is listed on the Hong Kong Stock Exchange (XHKG).
